Biogen Idec 4Q Revenues: $633 million (+8%) 4Q Earnings: $56 million (+94%) FY Revenues: $2.4 billion (+10%) FY Earnings: $161 million (+541%) Comments: Revenues for the quarter and full year were driven by Rituxan and Avonex. Rituxan revenues were up 15% to $709 million and Avonex sales were up 9% to $1.5 billion for the year. Rituxan revenues were up 6% to $182 million and Avonex sales were up 12% to $413 million for the quarter. Revenues for the quarter and full year inc...